NCT06330870Recruiting
Brain Metastasis Development Mechanism in BCBM Patients
Evaluation of Brain Metastasis Development Mechanism in Patients With Breast Cancer With Brain Metastasis(BCBM)
Source: ClinicalTrials.gov · Last updated 26 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is the experimental study for brain metastasis development mechanism in patients with breast cancer with brain metastasis
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 6 Feb 2024
- Start date
- 6 Apr 2023
- Primary completion date
- 5 Feb 2025
- Lead sponsor
- Samsung Medical Center
- Diseases
- Childhood cancers
- NCT number
- NCT06330870
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 6 Apr 2023 to the primary completion date, 5 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Gamma Knife surgery patient
Who the study is looking for
- Breast cancer
- Brain metastasis curative surgery patient
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ji-Yeon Kim Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.